Artigos com autorizações de acesso público - Jorge MarreroSaiba mais
9 artigos não disponíveis publicamente
Modern diagnosis and management of hepatocellular carcinoma
JA Marrero, T Welling
Clinics in liver disease 13 (2), 233-247, 2009
Autorizações: US National Institutes of Health
Diagnostic and therapeutic delays in patients with hepatocellular carcinoma
A Rao, NE Rich, JA Marrero, AC Yopp, AG Singal
Journal of the National Comprehensive Cancer Network 19 (9), 1063-1071, 2021
Autorizações: US National Institutes of Health
Elevated serum IL-8 is associated with the presence of hepatocellular carcinoma and independently predicts survival
TH Welling, S Fu, S Wan, W Zou, JA Marrero
Cancer investigation 30 (10), 689-697, 2012
Autorizações: US National Institutes of Health
Treatment of primary biliary cirrhosis with tetrathiomolybdate: results of a double-blind trial
F Askari, D Innis, RB Dick, G Hou, J Marrero, J Greenson, GJ Brewer
Translational Research 155 (3), 123-130, 2010
Autorizações: US National Institutes of Health
Clinical outcomes of patients with Liver Imaging Reporting and Data System 3 or Liver Imaging Reporting and Data System 4 observations in patients with cirrhosis: A systematic …
M Kanneganti, JA Marrero, ND Parikh, F Kanwal, T Yokoo, ...
Liver Transplantation 28 (12), 1865-1875, 2022
Autorizações: US National Institutes of Health
High neutrophil–lymphocyte ratio and delta neutrophil–lymphocyte ratio are associated with increased mortality in patients with hepatocellular cancer
NE Rich, A Parvathaneni, A Sen, M Odewole, A Arroyo, AR Mufti, TA Kerr, ...
Digestive Diseases and Sciences 67 (6), 2666-2676, 2022
Autorizações: US National Institutes of Health, Cancer Prevention Research Institute of …
Outcomes of simultaneous liver kidney transplantation in patients with hepatocellular carcinoma
N Rich, B Tanriover, AG Singal, JA Marrero
Transplantation 101 (1), e12-e19, 2017
Autorizações: US National Institutes of Health
Reply to:“Correction for length bias reduces the mortality benefit from hepatocellular carcinoma surveillance”
AG Singal, J Marrero, ND Parikh
Journal of Hepatology 79 (2), e90-e92, 2023
Autorizações: US National Institutes of Health
Screening for hepatocellular carcinoma in viral liver disease: any new biomarkers on the horizon?
S Bangaru, JA Marrero, AG Singal
Clinical Dilemmas in Viral Liver Disease, 15-18, 2020
Autorizações: US National Institutes of Health, Cancer Prevention Research Institute of …
86 artigos disponíveis publicamente
Surveillance imaging and alpha fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis
K Tzartzeva, J Obi, NE Rich, ND Parikh, JA Marrero, A Yopp, AK Waljee, ...
Gastroenterology 154 (6), 1706-1718. e1, 2018
Autorizações: US National Institutes of Health, US Department of Veterans Affairs
Meta‐analysis: surveillance with ultrasound for early‐stage hepatocellular carcinoma in patients with cirrhosis
A Singal, ML Volk, A Waljee, R Salgia, P Higgins, MAM Rogers, ...
Alimentary pharmacology & therapeutics 30 (1), 37-47, 2009
Autorizações: US National Institutes of Health
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial
J Bruix, JL Raoul, M Sherman, V Mazzaferro, L Bolondi, A Craxi, PR Galle, ...
Journal of hepatology 57 (4), 821-829, 2012
Autorizações: US National Institutes of Health, Government of Spain
α-fetoprotein, des-γ carboxyprothrombin, and lectin-bound α-fetoprotein in early hepatocellular carcinoma
JA Marrero, Z Feng, Y Wang, MH Nguyen, AS Befeler, LR Roberts, ...
Gastroenterology 137 (1), 110-118, 2009
Autorizações: US National Institutes of Health
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
AG Singal, JM Llovet, M Yarchoan, N Mehta, JK Heimbach, LA Dawson, ...
Hepatology 78 (6), 1922-1965, 2023
Autorizações: US National Institutes of Health, Cancer Research UK
Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease
S Cermelli, A Ruggieri, JA Marrero, GN Ioannou, L Beretta
PloS one 6 (8), e23937, 2011
Autorizações: US National Institutes of Health
Hepatobiliary cancers
AB Benson, TA Abrams, E Ben-Josef, PM Bloomston, JF Botha, BM Clary, ...
Journal of the National Comprehensive Cancer Network 7 (4), 350-391, 2009
Autorizações: US National Institutes of Health
Comparison of imputation methods for missing laboratory data in medicine
AK Waljee, A Mukherjee, AG Singal, Y Zhang, J Warren, U Balis, ...
BMJ open 3 (8), e002847, 2013
Autorizações: US National Institutes of Health
The effect of PNPLA3 on fibrosis progression and development of hepatocellular carcinoma: a meta-analysis
AG Singal, H Manjunath, AC Yopp, MS Beg, JA Marrero, P Gopal, ...
Official journal of the American College of Gastroenterology| ACG 109 (3 …, 2014
Autorizações: US National Institutes of Health
Identification of osteopontin as a novel marker for early hepatocellular carcinoma
S Shang, A Plymoth, S Ge, Z Feng, HR Rosen, S Sangrajrang, P Hainaut, ...
Hepatology 55 (2), 483-490, 2012
Autorizações: US National Institutes of Health
Trial design and endpoints in hepatocellular carcinoma: AASLD consensus conference
JM Llovet, A Villanueva, JA Marrero, M Schwartz, T Meyer, PR Galle, ...
Hepatology 73, 158-191, 2021
Autorizações: Cancer Research UK
As informações de publicação e financiamento são determinadas automaticamente por um programa de computador